doi:10.1163/156856208784909435
Always consult a healthcare provider or veterinarian for the correct route and dosage
Thus, with such a background (i.e., useful modulation/control of the increased angiogenesis, elevated VEGF levels, upregulation of the egr-1 gene, enhanced NO and eNOS stimulation, and counteraction of increased free radical formation), stable gastric pentadecapeptide BPC 157 is working as a cytoprotective agent (and, therefore, with a highly postulated safety profile) (and not as a panacea effective for all conditions)
For the skin-and-connective-tissue-quality use case KLOW was built for, the research default is monotherapy the blend already addresses inflammation, perfusion, migration, and remodeling